Effect of Platelet-rich Plasma (PRP) Injection on Knee Osteoarthritis
Study Details
Study Description
Brief Summary
To evaluate the safety and effectiveness of PRP injection therapy in the repair of osteoarthritis and periarticular soft tissue injury through a single-center, exploratory clinical study, and to provide a more reliable basis for the treatment of joint injury.
Condition or Disease | Intervention/Treatment | Phase |
---|---|---|
|
N/A |
Study Design
Arms and Interventions
Arm | Intervention/Treatment |
---|---|
No Intervention: Preoperative
|
|
Experimental: postoperative (6 weeks) The patients were injected with PRP. |
Drug: Sodium hyaluronate injection
The control group was injected into the joint cavity with sodium hyaluronate injection..
|
Experimental: postoperative (3 months) The patients were injected with PRP. |
Drug: Sodium hyaluronate injection
The control group was injected into the joint cavity with sodium hyaluronate injection..
|
Outcome Measures
Primary Outcome Measures
- X-ray [pre-operation,3 weeks after treatment, 6 months after treatment]
The postoperative plain X-ray film was utilized for the assessment of knee joint deformity, stenosis of the joint space, and hyperplasia of osteophytes.
- CT [pre-operation,3 weeks after treatment, 6 months after treatment]
The application of three-dimensional CT scan for the assessment of articular cartilage defects.
- MRI [pre-operation,3 weeks after treatment, 6 months after treatment]
The injury of ligaments, meniscus, and the knee joint was assessed using MRI.
Eligibility Criteria
Criteria
Inclusion Criteria:
-
The age range of the participants was 20 to 60 years old. Through a comprehensive clinical and imaging examination, it was conclusively determined that the individuals had knee osteoarthritis or experienced injuries to the cart, and meniscus surrounding the knee joint.
-
The preoperative routine tests and examinations revealed no contraindications.
-
Revised sentence: "Informed consent of the patient
Exclusion Criteria:
-
The platelet count or function exhibits significant abnormalities、Systemic infection transmitted through the bloodstream.
-
Prolonged usage of anti-inflammatory drugs and systemic corticoid administration.
-
In injection site or damage to the skin.
-
Patients with tumors or undergoing radiotherapy and chemotherapy.
-
Pregnant or breastfeeding women.
-
Individuals with mental illnesses who are unable to cooperate with follow-up procedures.
-
Contraindications for MRI、Patients or their families do consent to participate in the study.
-
Other circumstances that render participation in the study unsuitable.
Contacts and Locations
Locations
Site | City | State | Country | Postal Code | |
---|---|---|---|---|---|
1 | Xijing Hospital | Xi'an | Shannxi | China | 710034 |
Sponsors and Collaborators
- Xijing Hospital
Investigators
None specified.Study Documents (Full-Text)
None provided.More Information
Publications
- Ramos-Gonzalez G, Salazar L, Wittig O, Diaz-Solano D, Cardier JE. The effects of mesenchymal stromal cells and platelet-rich plasma treatments on cutaneous wound healing. Arch Dermatol Res. 2023 May;315(4):815-823. doi: 10.1007/s00403-022-02451-y. Epub 2022 Nov 3.
- Zhang Y, Xing F, Luo R, Duan X. Platelet-Rich Plasma for Bone Fracture Treatment: A Systematic Review of Current Evidence in Preclinical and Clinical Studies. Front Med (Lausanne). 2021 Aug 3;8:676033. doi: 10.3389/fmed.2021.676033. eCollection 2021.
- KY20232210